IN A WORLD OF 1064 POSSIBILITIES, QUALITY WINS OVER QUANTITY.
Discover how LCC’s proprietary chemistry platform is accelerating the discovery and development of small molecule drug candidates by accessing novel 3D chemical space.
PACE™ Platform
The PACE™ platform is designed to develop potential small molecule drug candidates by utilizing novel, chiral, diverse chemical libraries for hit identification, with a design-driven intelligence that facilitates efficient hit follow-up, and further enhanced by a co-located automation laboratory.
Our Experts & team
Our team is at the heart of our success. Comprising scientists, researchers, and industry specialists, each member brings a wealth of experience and unique insights. Together, we foster a collaborative environment that pushes the boundaries of what’s possible in chiral compound development.
Partners
By working closely with our partners, we expand our capabilities and gain deeper insights that drive each stage of the development process.
